Welcome to our dedicated page for HERITAGE CANNABIS HLDGS news (Ticker: HERTF), a resource for investors and traders seeking the latest updates and insights on HERITAGE CANNABIS HLDGS stock.
Heritage Cannabis Holdings Corp. (HERTF) provides investors and industry observers with essential updates through this centralized news hub. Track official press releases, strategic developments, and operational updates from the cannabis-focused asset management company.
Discover timely information about corporate restructuring initiatives under the Companies' Creditors Arrangement Act (CCAA), portfolio optimization efforts, and regulatory compliance milestones. This resource aggregates earnings announcements, asset transaction details, and management commentary to support informed market analysis.
Key updates include production capacity changes, partnership developments, and financial restructuring progress. The curated collection serves as a reliable reference for understanding HERTF's position within evolving cannabis markets and its approach to operational resilience.
Bookmark this page for streamlined access to verified corporate communications. Check regularly for new filings and strategic updates directly from Heritage Cannabis Holdings and authorized news sources.
Heritage Cannabis Holdings Corp. (OTCQX: HERTF) announces the launch of its CB4 branded medical cannabis products through its subsidiary Opticann in Canada. The product line includes CB4 Relief-T Softgels, Relief Deep Rub Gel, and Control CBD & CBDA filmstrips, all developed with advanced pharmaceutical technologies. The company plans to expand the range with additional products, including CB4 Derma skin cream and Clear face gel. Heritage aims to improve patient access to effective cannabis-based treatments backed by clinical data.
Heritage Cannabis Holdings Corp. (CSE: CANN; OTCQX: HERTF) has granted 13,875,000 stock options to its directors, officers, employees, and consultants. These options are priced at $0.10 per share and set to expire on September 17, 2026. The vesting schedule includes a third vesting upon grant, another third in twelve months, and the final third in twenty-four months. The company, a leader in the cannabis industry, operates two licensed manufacturing facilities in Canada and offers a range of products under various brands.
Heritage Cannabis Holdings Corp. announced a term sheet with Merida Capital Partners IV LP for up to USD$1.5 million in Senior Unsecured Convertible Promissory Notes to fund its expansion into
Heritage Cannabis Holdings Corp. (CSE: CANN, OTCQX: HERTF) has launched a private label program (PLP) in partnership with High Tide Inc. (Nasdaq: HITI) to produce Cabana Cannabis Co. branded shatter for distribution across Ontario, Manitoba, Saskatchewan, and Alberta. Heritage, a top three concentrates producer in Canada, aims to leverage its manufacturing expertise to expand its market presence. The agreement's success hinges on listing approval and may lead to further jurisdictional expansions.
Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) reported record unaudited sales of $3.2M for July 2021, marking the fifth consecutive month of record sales. The growth is attributed to innovative product launches and expanded distribution. Gross margins also reached a monthly high, while SG&A costs declined as a percentage of revenue. The company leads in vape and concentrate segments, with significant market share gains. Management remains focused on strategic growth and expects continued revenue increase from new product rollouts, including dried cannabis and concentrate offerings.
Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) has entered an exclusive licensing agreement with Avicanna Inc. to commercialize advanced CBD-based topical products under Heritage’s medical brands in Canada. This three-year agreement allows Heritage to market Avicanna's proprietary formulations, supported by pre-clinical studies and human trials. The products aim to meet the medical needs of cannabis patients and will launch in Q4 2021. Heritage is committed to meeting minimum sales requirements and will pay royalties to Avicanna for each unit sold.
Heritage Cannabis Holdings Corp. has announced significant changes to its leadership, with Donald Ziraldo resigning from the Board and Clint Sharples stepping down as CEO. David Schwede, previously President of Recreational, has been appointed as the new CEO. Schwede, known for scaling Premium 5 to profitability, is expected to drive sequential revenue growth and expand distribution, including U.S. market entry by year-end. Max Gerard has also resigned from the Board but will continue as an advisor while awaiting regulatory clearance.
Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) announces substantial growth in recreational product distribution across Canada. In Q2, the firm experienced a remarkable 250% increase in revenue compared to Q1 2021. Key highlights include a 164% month-over-month growth in vape sales in Ontario and 175% growth in New Brunswick. Heritage has launched 61 SKUs in Quebec and expanded into Saskatchewan and Manitoba. The Medical Division is set to introduce its first six Opitcann medical products, enhancing its market presence. The company aims for further expansion into the U.S. market by year's end.
Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) announces its expansion into Newfoundland and Labrador with a new order from the Newfoundland and Labrador Liquor Corporation. This order includes five brands: Purefarma, Pura Vida, RAD, Premium 5, and feelgood, totaling 27 SKUs. Starting in July, these products will be available in Tweed locations across the province. The company’s President of the Recreational Division highlighted strong performance in the concentrates category across Canada, indicating robust demand for Heritage’s products.
